| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $2,845,584 ) |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01GM152704 | Development of protein-based nanostructures activated by ultrasound | 000 | 2 | NIH | 1/27/2025 | $315,903 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01DC011579 | Taste and Somatosensory Processing | 000 | 14 | NIH | 2/18/2025 | $342,645 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01AI132836 | Permeability barriers of Gram-negative pathogens and approaches to bypass them | 000 | 8 | NIH | 3/31/2025 | $455,323 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | P20GM135009 | Oklahoma Center of Medical Imaging for Translational Cancer Research | 000 | 4 | NIH | 1/7/2025 | $2,035,962 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01CA269897 | Potentiating a systemic antitumor response by interstitial localized ablative immunotherapy to synergize with immune checkpoint therapy for metastatic pancreatic tumors | 002 | 4 | NIH | 3/3/2025 | $440,203 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01AI187294 | Intermembrane transport of lipids and metabolites by mycobacterial MmpL protein complexes | 000 | 1 | NIH | 11/27/2024 | $811,396 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R03AI175981 | Characterizing mechanisms of immune protection by the bacterial type II-A CRISPR systems | 000 | 2 | NIH | 1/3/2025 | $70,990 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01GM138800 | A Chemoenzymatic Approach to Accessing Novel Isoprenoid Scaffolds | 000 | 4 | NIH | 12/12/2024 | $279,261 |
| | 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01CA269897 | Potentiating a systemic antitumor response by interstitial localized ablative immunotherapy to synergize with immune checkpoint therapy for metastatic pancreatic tumors | 001 | 3 | NIH | 2/13/2025 | $0 |
| | 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R35GM153297 | Multiscale Modeling of Enzymatic Reactions and Bioimaging Probes | 000 | 1 | NIH | 11/7/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | H79SP084324 | South Southwest Prevention Technology Transfer Center (SSW PTTC) | 000 | 1 | SAMHSA | 3/13/2025 | $0 |
| | 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01HD109157 | Shift from Unilateral to Bilateral Sensory-Motor Connectivity in Chronic Hemiparetic Stroke | 001 | 2 | NIH | 2/26/2025 | -$1 |
| | 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R25CA274172 | Native American Youths Enjoy Science - YES Oklahoma | 000 | 2 | NIH | 3/14/2025 | -$255,645 |
| | 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | H79SP081501 | The purpose of the SWPC SPF-PFS is to prevent the onset and reduce the progression of substance abuse and related problems while strengthening prevention capacity and infrastructure in the community. | 001 | 5 | SAMHSA | 2/14/2025 | -$300,000 |
| | 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01HL159475 | Improving outcomes in endovascular treatment of intracranial aneurysms: Combining additive manufacturing, in-silico modeling, and shape memory polymers | 001 | 2 | NIH | 3/19/2025 | -$660,306 |
| | 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | F31CA261044 | Tumor-Specific Nanocontrast Agents for Improved Detection of Pancreatic Cancer | 001 | 2 | NIH | 12/20/2024 | -$1,200 |
| | 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | F31CA261044 | Tumor-Specific Nanocontrast Agents for Improved Detection of Pancreatic Cancer | 000 | 2 | NIH | 11/25/2024 | -$2,413 |
| | 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | H79SP081152 | The STOP ACT Project (SAP) at the University of Oklahoma Southwest Prevention Center targets the local community conditions regarding alcohol use by youth and young adults ages 12-20. | 001 | 4 | SAMHSA | 1/13/2025 | -$50,000 |
| | 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01AI170605 | Deciphering the mechanism of action of carnitine, a novel treatment for chronic Chagas disease | 000 | 2 | NIH | 1/21/2025 | -$35,438 |
| | 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01CA269897 | Potentiating a systemic antitumor response by interstitial localized ablative immunotherapy to synergize with immune checkpoint therapy for metastatic pancreatic tumors | 000 | 2 | NIH | 1/28/2025 | $0 |
| | 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01AI177469 | Novel single-cell mass spectrometry methods to assess the role of intracellular drug concentration and metabolism in antimicrobial treatment failure | 000 | 1 | NIH | 12/11/2024 | -$1 |
| | 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | NH28CE003511 | McClain County Drug Free Communities | 01 | 2 | CDC | 10/2/2024 | $0 |
| | 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R25HG010132 | Programs for the Training and Advancement of the Next GENeration of Native Researchers in Genetics, Ethics and Society | 001 | 5 | NIH | 10/23/2024 | $0 |
| | 2025 | 2022 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01HD109157 | Shift from Unilateral to Bilateral Sensory-Motor Connectivity in Chronic Hemiparetic Stroke | 000 | 1 | NIH | 2/26/2025 | -$124,302 |
| | 2025 | 2022 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01HL159475 | Improving outcomes in endovascular treatment of intracranial aneurysms: Combining additive manufacturing, in-silico modeling, and shape memory polymers | 000 | 1 | NIH | 3/19/2025 | -$208,536 |
| | 2025 | 2022 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | H79SP081501 | The purpose of the SWPC SPF-PFS is to prevent the onset and reduce the progression of substance abuse and related problems while strengthening prevention capacity and infrastructure in the community. | 000 | 4 | SAMHSA | 2/14/2025 | -$256,978 |
| | 2025 | 2022 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R03AI163845 | Small Molecule Inhibition of a Multidrug Efflux Pump of Pseudomonas aeruginosa | 000 | 2 | NIH | 1/13/2025 | $0 |
| | 2025 | 2022 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | H79SP081152 | The STOP ACT Project (SAP) at the University of Oklahoma Southwest Prevention Center targets the local community conditions regarding alcohol use by youth and young adults ages 12-20. | 000 | 3 | SAMHSA | 1/13/2025 | -$11,278 |
| | 2025 | 2022 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R35GM127107 | Factors Influencing Scientific Research Careers among American Indians | 000 | 5 | NIH | 11/6/2024 | $0 |
| | 2025 | 2022 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R25HG010132 | Programs for the Training and Advancement of the Next GENeration of Native Researchers in Genetics, Ethics and Society | 000 | 5 | NIH | 10/10/2024 | $0 |
| | 2025 | 2021 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R21AR077800 | Introducing a Chondroinductive Peptide | 000 | 1 | NIH | 12/16/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $9,986,262 ) (Continued on the next page) |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 201 Stephenson Parkway | Norman | OK | 73019-9705 | CLEVELAND | USA | 90YR0133 | Happy Teacher Wellness Program to Support Head Start Staff's Well-Being | 00 | 4 | ACF | 7/8/2024 | $495,075 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01DC011579 | Taste and Somatosensory Processing | 001 | 13 | NIH | 5/2/2024 | $38,072 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01DC011579 | Taste and Somatosensory Processing | 000 | 13 | NIH | 2/5/2024 | $342,645 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01CA269897 | Potentiating a systemic antitumor response by interstitial localized ablative immunotherapy to synergize with immune checkpoint therapy for metastatic pancreatic tumors | 001 | 3 | NIH | 4/17/2024 | $24,475 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01CA269897 | Potentiating a systemic antitumor response by interstitial localized ablative immunotherapy to synergize with immune checkpoint therapy for metastatic pancreatic tumors | 000 | 3 | NIH | 3/8/2024 | $440,527 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01GM152704 | Development of protein-based nanostructures activated by ultrasound | 001 | 1 | NIH | 6/12/2024 | $72,100 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01GM152704 | Development of protein-based nanostructures activated by ultrasound | 000 | 1 | NIH | 1/15/2024 | $363,919 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01DC020843 | Temperature and thermogustatory preferences | 000 | 2 | NIH | 6/7/2024 | $477,443 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | K25CA270079 | Computational approaches to the mechanistic elucidation of the serrated pathway of human colon carcinogenesis | 000 | 2 | NIH | 7/12/2024 | $198,721 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R21EY034326 | Characterizing the prevalence and nature of facial recognition deficits in non-proliferative diabetic retinopathy | 000 | 2 | NIH | 5/30/2024 | $206,229 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R35GM151086 | Epigenetic and transcriptional mechanisms driving human pigmentation diversity | 000 | 1 | NIH | 5/30/2024 | $249,817 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R35GM151086 | Epigenetic and transcriptional mechanisms driving human pigmentation diversity | 001 | 2 | NIH | 7/2/2024 | $373,297 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R00ES033257 | Linking genomic, physiological, and behavioral responses using a Drosophila model of heavy metal stress | 001 | 4 | NIH | 8/14/2024 | $248,999 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R35GM147397 | A multi-level mass spectrometry pipeline for the analysis of whole proteoforms and their complexes | 000 | 3 | NIH | 7/2/2024 | $380,398 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | H79SP083220 | Strategic Prevention Framework for Prescription Drugs | 001 | 3 | SAMHSA | 7/16/2024 | $500,000 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R35GM153297 | Multiscale Modeling of Enzymatic Reactions and Bioimaging Probes | 000 | 1 | NIH | 5/17/2024 | $394,119 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | F31HD113221 | Network mechanisms underlying core behavioral features in Fragile X Syndrome | 001 | 1 | NIH | 8/15/2024 | $0 |
|
